News Focus
News Focus
icon url

BeDub

03/29/14 10:46 AM

#72237 RE: takeachance2012 #72236

That's the commercialization phase statement that didn't happen. Excellent example of their deception. Here's some more, right from their press releases shown in the news above.

The components of the campaign include intelligent "In-Stream TV Ads" via YouTube, which began airing March 10th, 2014, and will continue over the next several months.



Fuse will begin broadcasting the "Respect the Power" campaign on select national and regional networks over the next 30 days in support of current in-store advertising currently active in Walgreens stores across the country and on Walgreens.com. This campaign represents the next phase in progressive advertising by the Company that will include Powered By Fuse® world-class athletes doing the extraordinary.



The ads will run on cable and standard television reaching a combined 80 million households across multiple networks with the objective of introducing Fuse products and educating consumers on what it means to be "Powered By Fuse!®"



Fuse Science has expanded strategic talks to the leading producers of Estrodial in the hormone replacement category as part of the company's structure active M&A and licensing process.



"We have been anxiously awaiting the results of the AREDS2 study, so that we could incorporate the findings into the new Macular Health Drop Formulation. The ideal Drop formulation is well underway and we expect to begin clinical testing in July," said Macular Health's Chief Executive officer, Jeffery McAnnally. "We believe this study paves the way for an even bigger relationship between Macular Health and Fuse Science."



Fuse Science will continue its work with the New York-based investment banking firm Atlas Strategic Advisors (www.atlasadvisors.com) to explore strategic transactions involving Fuse's proprietary technology. Additionally, Fuse Science will be advised by Gaurav Kapoor, former Managing Partner and Principal at New England Consulting Group, where he worked for 15 years, leading landmark M&A and licensing transactions in the pharmaceutical and consumer package goods industries.


icon url

itlogic

03/29/14 11:05 AM

#72240 RE: takeachance2012 #72236

Macular Health has joined with Fuse Science to produce a new, patented drop for its new MacuDrop™ AREDS II Formula. Fuse Science is a consumer products and delivery technology company that is developing new technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals.

A combination of patent pending technology and trade secrets has resulted in this unique oral delivery system for nutraceuticals providing maximal delivery of nutrients across the oral mucosa. Nutrients are now encapsulated at a far greater concentration.

MacuDrop™ offers an easy to use alternative to daily capsule intake while providing maximum

=================================================================

Seeing that they joint forces to produce something that doesn't exist, I would think its fair to say it failed. Nothing was licensed. Was there ever a line item under "income" on any of their financial statements that showed money received for licensing?